[APASL2013]Entecavir versus Other Standard-of-Care for up to 4 Years in Nucleos(t)ide-naïve Patients with CHB in a Chinese Clinical Practice Setting

发表时间：2013-06-07 标签： 摘要赏析 乙肝 摘要赏析 相关搜索： CHB NUC oSOC HCV ETV